substance p has been researched along with Dyskinesia, Drug-Induced in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, S; Hong, S; Jang, J; Jeon, S; Jung, YR; Kim, J; Oh, JY; Park, HJ; Park, SU; Shin, HS; Song, MA; Song, TJ | 1 |
| Collier, TJ; Gebremedhin, KG; O'Malley, J; Paumier, KL; Rademacher, DJ; Sisson, KA; Sortwell, CE; Stancati, JA; Steece-Collier, K | 1 |
| Gao, DM; Jiao, JJ; Zhuang, XY | 1 |
| Chiken, S; Tokuno, H | 1 |
| Blum, I; Korczyn, AD | 1 |
| Egan, MF; Hurd, Y; Hyde, TM; Kleinman, JE; Weinberger, DR; Wyatt, RJ | 1 |
| Asanuma, M; Kawada, Y; Mori, A; Ogawa, N | 1 |
| Chesselet, MF; Delfs, JM; Ellison, GD; Mercugliano, M | 1 |
| Bachus, SE; Egan, MF; Ferguson, J; Hamid, EH; Hurd, Y; Hyde, TM | 1 |
| Damier, P; Féger, J; Hirsch, EC; Tremblay, L | 1 |
| Gunne, L; Häggström, JE; Johansson, PE; Terenius, L | 1 |
| Gunne, LM; Häggström, JE; Johansson, P; Levin, ED; Terenius, L | 1 |
3 review(s) available for substance p and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Peptide neurotransmitters and their implications for the treatment of tardive dyskinesia.
Topics: Animals; Brain; Cholecystokinin; Dipeptides; Dopamine; Dyskinesia, Drug-Induced; Endorphins; Female; Humans; Morphine; Naloxone; Neuropeptides; Neurotensin; Neurotransmitter Agents; Peptides; Peptides, Cyclic; Rats; Substance P | 1983 |
[Development of dyskinesias induced by treatment for Parkinson's disease: potential role of first exposure to L-DOPA (or phenomenon of priming)].
Topics: Animals; Antiparkinson Agents; Biological Transport, Active; Corpus Striatum; Disease Models, Animal; Dyskinesia, Drug-Induced; Enkephalins; Haplorhini; Humans; Levodopa; Neural Pathways; Neuronal Plasticity; Neurons, Efferent; Parkinson Disease; Receptors, Dopamine D2; Substance P; Time Factors | 2000 |
Neurobiochemical changes in tardive dyskinesia.
Topics: Animals; Antipsychotic Agents; Apomorphine; Cebus; Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Rats; Substance P; Substantia Nigra | 1988 |
9 other study(ies) available for substance p and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Effects of a combination treatment of KD5040 and
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Dopamine and cAMP-Regulated Phosphoprotein 32; Dyskinesia, Drug-Induced; Enkephalins; Extracellular Signal-Regulated MAP Kinases; Levodopa; Magnoliopsida; Male; Mice, Inbred C57BL; Movement; Parkinson Disease; Phytotherapy; Plant Extracts; Proto-Oncogene Proteins c-fos; Substance P | 2017 |
Interrogating the aged striatum: robust survival of grafted dopamine neurons in aging rats produces inferior behavioral recovery and evidence of impaired integration.
Topics: Aging; Amphetamine; Animals; Corpus Striatum; Disease Models, Animal; Dopamine and cAMP-Regulated Phosphoprotein 32; Dopaminergic Neurons; Dyskinesia, Drug-Induced; Embryo, Mammalian; Functional Laterality; Levodopa; Neurites; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-fos; Rats; Rats, Inbred F344; Recovery of Function; Stem Cell Transplantation; Substance P | 2015 |
[The effects of intranigral microinjection of substance P on apomorphine-induced rotational behavior in 6-OHDA lesions rats].
Topics: Animals; Apomorphine; Behavior, Animal; Dyskinesia, Drug-Induced; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Rotation; Substance P; Substantia Nigra | 2001 |
Impairment of skilled forelimb use after ablation of striatal interneurons expressing substance P receptors in rats: an analysis using a pasta matrix reaching task.
Topics: Animals; Corpus Striatum; Dyskinesia, Drug-Induced; Feeding Behavior; Female; Forelimb; Interneurons; Male; Motor Skills; Neural Pathways; Neurotoxins; Rats; Rats, Wistar; Receptors, Neurokinin-1; Substance P | 2005 |
Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesias.
Topics: Animals; Basal Ganglia Diseases; Dynorphins; Dyskinesia, Drug-Induced; Enkephalins; Glutamate Decarboxylase; Haloperidol; In Situ Hybridization; Male; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Substance P | 1994 |
Neuropeptide levels in discrete brain regions in the iminodipropionitrile-induced persistent dyskinesia rat model.
Topics: Animals; Brain; Catecholamines; Dyskinesia, Drug-Induced; Enkephalin, Methionine; Neuropeptides; Nitriles; Rats; Sincalide; Somatostatin; Substance P; Thyrotropin-Releasing Hormone | 1995 |
Expression of glutamic acid decarboxylase mRNA in striatum and pallidum in an animal model of tardive dyskinesia.
Topics: Animals; Corpus Striatum; Dyskinesia, Drug-Induced; Enkephalins; Female; Gene Expression; Globus Pallidus; Glutamate Decarboxylase; Haloperidol; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substance P | 1995 |
Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Corpus Striatum; Dynorphins; Dyskinesia, Drug-Induced; Enkephalins; Haloperidol; In Situ Hybridization; Male; Mastication; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substance P | 1996 |
Neuropeptide changes in a primate model (Cebus apella) for tardive dyskinesia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Brain Chemistry; Cebus; Corpus Striatum; Disease Models, Animal; Dynorphins; Dyskinesia, Drug-Induced; Female; Globus Pallidus; Glutamate Decarboxylase; Homovanillic Acid; Male; Neuropeptides; Substance P; Substantia Nigra | 1990 |